Morgan Bradley Paul

SVP Drug Discovery & Early Dev at CYTK

Sold, on record
$1.8M
Dollars the filings state
Form 4 sales
1
Latest Aug 31, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • CYTKCYTOKINETICS INCSVP Drug Discovery & Early Dev

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale CYTKUnusual
    Aug 31, 2017 2017

    Sold 118,330 shares at $15.00 ($1.8M)

    Morgan Bradley Paul, SVP Drug Discovery & Early Dev

    Sold 71.8% of holdings ($2.5M position)46,441 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Morgan Bradley Paul
Source
Aug 31, 2017Sep 1, 2017CYTKSVP Drug Discovery & Early DevForm 4 sale118,330$1.8M71.8%UnusualSEC